Lopende projecten
In dit overzicht vindt u informatie over lopende onderzoeken waarbij data van SHM worden gebruikt. De lijst is gefilterd en toont alleen projecten die beschikbaar zijn voor een breed publiek. Wilt u meer weten over de stand van zaken in een project of een overzicht van de laatste publicaties, bekijk dan de publicaties in ons jaarverslag.
Bekijk het laatste jaarverslag
| SHM nr. | Titel project | Auteur(s) |
| I25139 |
Baseline genotyping in people living with HIV: factors predicting resistance |
S. van Roeden, L. Kampschreur, M. van Vonderen, A. Wensing, A. van Sighem |
| I24137 | Piloting the revised HIV late diagnosis definition - a multi-country study coordinated under the EuroTEST initiative | D. Raben, A.R. Stengaard, P. Kirwan, A. van Sighem, E. Op de Coul |
| I24135 | Investigating the regional internalised homonegativity, HIV stigma beliefs and their ecological associations with the regional HIV cascades among MSM in the Netherlands | K. Jonas, H. Wang, H. Zimmerman, J. Kolstee, A. van Sighem |
| I24134 | Two-Year Follow-up of SARS-CoV-2 Immunogenicity in People with HIV with CD4+ T-Cell Counts ≤350 versus >350 | K. Brinkman, B. Rijnders, A. Roukens, C. Rokx, M. Jonkees |
| I23133 | Attenuation of HIV severity by slightly deleterious mutations can explain the long-term trajectory of virulence evolution | K. Lythgoe, H. Longley, C. Frase |
| I23132 | Incidence of pneumococcal disease and herpes zoster in PLWH based on an integrated risk assessment for immunological status and age in order to make vaccination recommendations​​ | A. Bruns, A. Verbon, B. van Welzen, E. te Linde |
| I23131 | Predictors of early and late-stage hiv-diagnosis among individuals who acquired hiv-infection via (registered) heterosexual sex in four high-prevalent PHS-regions in the Netherlands (Haaglanden, Rotterdam-Rijnmond, Amsterdam, Utrecht) | K. te Paske, J. Hontelez, J. Brand, M. van den Elshout, E. Hoornenborg, H. Götz |
| I22128 | SPIRIT (Strategies to prevent HIV transmission, Increase Retention in care and Improve Treatment outcome in the Dutch Caribbean) – substudy transmission dynamics | M. Hofstra, D. van de Wetering, B. Rodenburg, S. Autar, A. Rosingh, E. Wilkinson, J. van Kampen, C. Rokx, S. Jurriaans, M. van der Valk, T. van der Laar, J. den Hollander, D. Struik |
| I22126 | Relationship between presence of the metabolic syndrome, metabolic dysfunction associated fatty liver disease and liver related outcomes in patients with HIV-HBV coinfection | M.J. Sonneveld, M. van der Valk, L. Patmore, A. Boyd, C. Smit |
| I22122 | Treatment of HIV-hepatitis B virus coinfection with and without tenofovir-containing antiretroviral therapy | A. Mohareb, A. Boyd, C. Smit, E. Hyle, M. van der Valk |
| I22120 | Spirit: Strategieën om verspreiding van hiv te voorkomen, de toegang tot en behoud in zorg te verbeteren en hiv-behandeling te optimaliseren | D. van de Wetering, A. Duits, L. Hofstra, A. Wensing, G. Rozhnova |
| I21116 | The therapeutic drug monitoring registry of antiretrovirals outcomes after bariatric surgery in the Netherlands- METAL - | L. Zino, D.M. Burger, A. Colbers, O. Richel, C. Rokx, J. Stalenhoef |
| I21115 | Outcomes of cervical cander screening in women living with HIV in Amsterdam | M.F. Schim van der Loeff, S.E. Geerlings, J.A. Kramer, H.R. Verhoeve, S.J. Bogers, D.A.M. Heideman, M.C.G. Bleeker, K. Brinkman, K. Sigaloff, M. van der Valk |
| I21114 | Know the local HIV epidemiology: map the numbers | H. Götz, D. Twisk, J. den Hollander, C. Rokx, A. van Sighem |
| I21113 | Prospects of HIV elimination among Dutch MSM by targeted screening, partner notification, and immediate ART initiation for acute HIV infection | G. Rozhnova, M. Werkman, M. Kretzschmar, A. van Sighem, P. Reiss, J. Heijne, M. Dijkstra, W. Zuilof, G. de Bree, M. Schim van der Loeff |
| I20111 | Limburg 4 zero: An integrated approach to reduce the number of HIV and sexually transmitted infections in Limburg | N. Dukers-Muijers, Y. Evers, H. Goense, R. Ackens, M. Pronk, R. van Crevel, O. Richel |
| I20110 | Clinical outcomes and inflammation in viremic and non-viremic HIV elite controllers in the Dutch Athena Cohort | A. Verbon, A. van der Ven, M. Netea, A. Groenendijk, W. Blok, M. Berrevoets |
| I19103 |
2000HIV Human Functional Genomics Partnership Programm (2000HIV study) |
A. van der Ven, M. Netea, L. Joosten, Q. de Mast, M. Jacobs-Cleophas, L. van Eekeren, M. Berrevoets, M. Blauw, A. Verbon, A. Groenendijk, W. Blok, W. Vos |
| I19100 | HIV treatment outcomes of transgender people versus the general HIV-positive population in the Netherlands |
C. Daans, E. Hoornenborg, M. den Heijer, |
| I18098 | Geospatial analyse and mapping of new HIV diagnoses, late presentations and testing practices in Amsterdam - "het GIS project" within the H-TEAM initiative | G. de Bree, M. Prins, L. Boehnke, C. Bozzacchi, P. Reiss, M. Heidenrijk, J. van Bergen, A. van Sighem, M. van Rooijen, M. Kroone, M. Groot-Bruinderink, O. Ratmann, E. op de Coul |
| I14065 | Incidence of hepatocellular carcinoma in HIV/HBV-coinfected patients: Implications for screening strategies | G. Wandeler, A. Rauch, P. Reiss, C. Smit, M. van der Valk, J. Arends |
| I13120 | SPREAD Program 3.0 - Surveillance of transmission of HIV- drug resistace | A.M.J. Wensing, C.A.B. Boucher, K. Brinkman, J. van der Meer, I. van de Ende, C. Richter, E. Schippers, D. de Vries-Sluijs, J. Schinkel, C. Smit |
| I12045 | A HIV-1 genome wide association study to identify viral determinants of HIV-1 plasma concentration (BEEHIVE) | F. de Wolf, B. Berkhout, M. Cornelissen, C. Fraser, P. Kellam, A. Gall, L. Gras, A. van Sighem |
| I08115 | Proposal for collaboration and data exchange between HMF and RIVM for nation HIV/AIDS surveillance and data transfer to ECDC in the context of EU obligations for reporting on HIV/AIDS | E. op den Coul, F. de Wolf, M. van der Sande, A. van Sighem, J. Vlug |
| I05513 | HIV Resistance Response Database Initiative (RDI) | A. Revell |